Obesity as a Disease - Our Position

Total Body Balance

Medical Weight Loss Center

Terms and Measuring Sticks
Weight Loss Programs Available Reverse Heart Disease Now Home Page
Articles About Our Program Heartfixer Welcome Page
Case Studies - 1st 25 Patients

at

Comprehensive Heart Care

Comprehensive Heart Care Home Page
New Patient Information Medical Topics Section
Total Body Balance Home Page

Outcome Statistics

This page presents our outcomes in graphic form.  Please refer to the Case Studies page for information regarding the treatment response and course of our first 25 patients.

                                                                                                     

Group Results - First 300 Female and First 130 Male Patients to complete an Initial Course of Modified hCG Therapy 
                  

 

 

 

 

 

 

 

 

Weight Loss by Female and Male Treatment Groups (30 Female and 10 Male Patients per Group)   
                                                                                                                                                       


                                             

 

 

 

 

 

 

                                              
                                        One Hundred Female Patients who have completed Two Courses of Modified hCG Therapy
                                    
Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and many utilized the 26 day protocol - their results are included. their                                                                                                                                                             

 

 

 

 

 

 

       

                                                                                      

                                             Ten Female Patients who have completed Three Courses of Modified hCG Therapy
                                    
Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the

 

 

 

 

 

 

 

 

 

                                             Thirty Four Male Patients have completed Two Courses of Modified hCG Therapy
                                            Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                   Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the                                                                                                                    

 

 

                                                    

 

                                           

 

                                              

 

First Ten Female Patients who have completed an Initial Course of Modified hCG Therapy             

                      

                                                
                                                

 

 

 

 

 



First Ten Male Patients who have completed an Initial Course of Modified hCG Therapy

                       

 

 

 

 

 

 

 

 

Fourteen Women and Eight Men have completed a 23 Day Initial Course of Modified hCG Therapy    

 

 

 

 

 

 

 

 

Second Ten Male Patients who have completed an Initial Course of Modified hCG Therapy    

                         

                                    

          

 

 

 

 

 

                  
            Second Ten Female Patients who have completed an Initial Course of Modified hCG Therapy
                                         

                         

                                        

                                

 

 

 

 

 

    
      Third Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy
 

 

                               
                                  

 

 

 

 

 

 
Third Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
                              

 

                                           

                                            

 

 

 

 

Fourth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy      

 

 

 

 

 

 

 

 

 

Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


 

 

 

 

 

 

 



Fifth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Fifth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 
 

 

 

 

 

  

 

 

Sixth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
       

 

 

 

 

     

 

 

 

Seventh and Eighth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Ninth and Tenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Seventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 


 

Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Ninth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Eleventh and Twelfth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirteenth and Fourteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Tenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Eleventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Twelfth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Thirteenth and Fourteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Fifteenth and Sixteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Seventeenth and Eighteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Nineteenth and Twentieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty First and Twenty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Twenty Third and Twenty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

Twenty Fifth and Twenty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty Seventh and Twenty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty Ninth and Thirtieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty First and Thirty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Patients with Limited Adherence to the Diet   

      Most of our patients followed the diet to the letter - and then were rewarded with a significant weight loss.  Others followed the diet most of the time, breaking away occasionally in relation to hunger or social obligations (we are all human); their statistics are included in the overall results.  The vast majority of our patients completed a 40 day program.  The 26 day patients are not included in the above statistics.  Also excluded from the main statistics and presented below are patients who did not follow the program most of the time.  As you can see, when you do not follow Dr. Simeons' guidelines you do not obtain a significant reduction in weight. 

   

 

 

 

 

 

 

 

Early Discontinuation
A small number of patients (»10% of those who start) stopped early or dropped out of the program for the reasons given below.

Patient Reason Patient Reason
W1dc Hunger; Lost Motivation M1dc Prostatitis
W2dc Hunger M2dc Fever and URI
W3dc No Return Call M3dc Disc Disease Flare Up
W4dc Lost hCG M4dc No Return Call
W5dc Lost Motivation M5dc Hunger & Frustration
W6dc Schedule Conflict M6dc-2 Lost Motivation Round Two
W7dc Lost Motivation M7dc No Return Call
W8dc Possible Allergy M8dc Diverticular Disease
W9dc No Return Call M9dc-2 Lost Motivation Round Two
W10dc-2 Lost Motivation Round 2 M10dc No Return Call
W11c No Return Call W33dc Migraine Headache
W12dc Surgery Required W34dc Quit
W13dc Lost Motivation W35dc Quit
W14dc Quit W36dc-2 Lost Motivation Round 2
W15dc-2 Lost Motivation Round 2 W37dc Quit
W16dc-2 Lost Motivation Round 2 W38dc Quit
W17dc Quit W39dc Quit
W18dc Caught a cold W40dc-2 Quit Round 2
W19dc Caught a cold W41dc Quit
W20dc No Return Call W42dc Quit
W21dc Lost Motivation W43dc Quit
W22dc Quit W44dc No Show
W23dc Quit W45dc No show
W24dc-3 Lost Motivation Round 3 W42dc No Show
W25dc Lost Motivation W43dc Quit
W26dc-2 Lost Motivation Round 2 W44dc Quit
W27dc-2 Lost Motivation Round 2 W45dc Quit
W28dc-3 Lost Motivation Round 3 W46dc-2 Lost Motivation Round 2
W29dc Lost Motivation W47dc Quit
W30dc No Return Call W48dc-2 Pneumonia
W31dc-2 Quit W49dc-2 Lost Motivation Round 2
W32dc-2 Refused Office Visits W50dc Quit
    W51dc-2 Lost Motivation Round 2
    W52dc Quit
    W53dc Quit
   

      Patients who dropped out or stopped early did so primarily due to loss of motivation and/or hunger.  We did not feel that the hCG program was the cause of M1dc's prostatitis, M3dc's disc disease flare up, M8dc's diverticular disease, or M2dc's upper respiratory tract infection.  However, 10 days later M2dc experienced gall bladder inflammation, leading to cholycystectomy (surgical removal of the gall bladder).  W98 also required cholycystectomy towards the end of her 40 day program.  Rapid weight reduction by any means can lead to inflammation within the gall bladder (probably only in individuals with pre-existent gall bladder disease but we cannot say this with certainty).  Thus our gall bladder event rate is approximately 0.4% of patients treated.  Two patients experienced a transient flare up of gout.  These side-effects of hCG-assisted weight reduction are not unexpected and are discussed by Dr. Simeons in his book.  Two female patients experienced upper respiratory infections and stopped early; we feel this was the seasonal flu and not a direct complication of their weight loss program.  One patient who was doing well was diagnosed with an unrelated problem and had to drop out early.  A small number of patients developed urinary tract infection or pneumonia while on the program.  These infections are likely incidental to weight loss, and not caused by weight loss.  However, if significant infection occurs, we counsel you to stop hCG and immediately increase caloric intake to a Phase 3 level, emphasizing protein over carbohydrate, as 500 calories a day is not sufficient when your physiology is marshaling its resources to defend you against bacterial invasion.  The program can be restarted (including the gorge days) after you have recovered.   

                                                                                                               Current Status (as of 7/30/10)

One Full Round of Weight Reduction Completed  300 Women and 130 Men

Two Rounds Completed

96 Women and 34 Men

Three Rounds Completed

18 Women and 3 Men

26 Day Round One Completed 14 Women and 8 Men

 Currently Undergoing Round One

   44 Women and 10 Men

Currently Undergoing Rounds Two or Three

  33 Women and 13 Men

Marked Dietary Non-Adherence

25 Women and 13 Men

Early Discontinuation of Round One

38 Women and 8 Men

Early Discontinuation of Subsequent Rounds

15 Women and 2 Men

Program Modified

2 Women

Cosmetic Weight Loss

4 Women

 

      Please Note -  It is the position of the FDA and FTC that HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity.  There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes more attractive or “normal” distribution of fat, or that it decrease the hunger and discomfort associated with calorie-restricted diets.